Study Shows Accuracy of Optical Biopsy Over Traditional Endoscopic Biopsy

Mauna Kea Technologies, a global optical biopsy company, recently conducted a study that showed its Cellvizio optical biopsy device had greater accuracy in detecting stomach cancer than traditional endoscopic biopsy.

Advertisement

Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!

The study conducted in Korea found that optical biopsy had a 91.7 percent accuracy rate in detecting stomach cancer, while traditional endoscopic biopsies had an 85.2 percent accuracy rate.

More Articles on Gastroenterology:

Memorial Hermann Northeast Hospital Names Dr. Howard Hamat Chief of Staff
CMS Requires Gastroenterologist to Document Quality of Care
Gastrointestinal Device Market Estimated at $33B by 2023

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.